Resources

AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.

To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database

Results

showing 1-10 of 43

HIV Cure and the Environment

AVAC and REACH for the Cure hosted a webinar to discuss how the environment may impact HIV cure strategies.

Prevention Option:

February 2024


African Civil Society Mobilization for PEPFAR Reauthorization

Join civil society organizations in PEPFAR recipient countries to discuss the status and political context of the current reauthorization and mobilize to call on the US Congress to recommit this life sustaining program. Bring your questions and please share this invitation widely in your relevant networks.

Prevention Option:

November 2023


Pandemic Accord Briefing for Civil Society & Community Partners

The Pandemic Accord negotiations are ongoing, and should come to fruition next year. What do they mean for your work, your country, and the future of global health? On Tuesday, November 21, 8:00 to 9:30 AM EST / 2:00 to 3:30 PM CEST, advocates came...

Prevention Option:

November 2023


Spotlight on New PrEP Tools and Data: From R&D to access

Tuesday, November 28 Between the recent accelerated growth in global PrEP initiations, and the introduction of new PrEP products like cabotegravir and the dapivirine vaginal ring, the field of PrEP data has never been more exciting or more...

Prevention Option:

November 2023


Let’s Talk About HIV Cure Research: An introduction to the science under investigation

This webinar explored what makes curing HIV so challenging, the strategies being pursued, and what is happening in locally in NYC!

Prevention Option:

November 2023


HPTN 096: Building Equity Through Advocacy – An Integrated, Status-Neutral Approach for Ending the Epidemic Among Black Gay Men in the South

The Choice Agenda and partners hosted a fascinating discussion about a novel, much-needed HIV prevention research study – HPTN 096 on November 15. Currently in the field, the study addresses social, structural, institutional, and behavioral barriers to HIV prevention and care. Visit the study website here.

Prevention Option:

November 2023


Results from STI Landscaping Analyses in East and Southern Africa—Parts 1 and 2

Hear results from STI landscaping projects conducted in seven different countries from East and Southern Africa that explored needs for STI vaccines and diagnostics.

November 2023


Boo, Syphilis is Really Back!

Syphilis rates have increased drastically in recent years. Learn how others are addressing these rising rates and the techniques clinicians are using to detect, treat, and prevent infections. Co-hosted with NACCHO and NNPTC. Webinar Recording /...

November 2023


DoxyPEP Implementation – All Systems Go?

On October 5, The Choice Agenda (TCA) and the National Coalition of STD Directors (NCSD) hosted a discussion on the roll out of Doxycycline as STI PEP for helping gay, bisexual, and other men who have sex with men and transgender women reduce bacterial STIs, including gonorrhea, chlamydia, and syphilis.

Prevention Option:

October 2023


How do People Who Use/Inject Drugs Intersect with PrEP Research and Service Delivery?

On Wednesday, September 6, The Choice Agenda (TCA), the International Network of People Who Use Drugs (INPUD) and our wonderful expert speakers discussed the health and wellness priorities of people who use/inject drugs, and how these communities (“key populations”) intersect across PrEP research, development, and implementation activities.

Prevention Option:

September 2023


showing 1-10 of 43